3-methylcholanthrene has been researched along with Minimal Disease, Residual in 2 studies
Methylcholanthrene: A carcinogen that is often used in experimental cancer studies.
3-methylcholanthrene : A pentacyclic ortho- and peri-fused polycyclic arene consisting of a dihydrocyclopenta[ij]tetraphene ring system with a methyl substituent at the 3-position.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Koebel, CM | 1 |
| Vermi, W | 1 |
| Swann, JB | 1 |
| Zerafa, N | 1 |
| Rodig, SJ | 1 |
| Old, LJ | 1 |
| Smyth, MJ | 1 |
| Schreiber, RD | 1 |
| Vlk, V | 1 |
| Rössner, P | 1 |
| Indrová, M | 1 |
| Bubeník, J | 1 |
| Sobota, V | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Effects of Epidural Anesthesia-analgesia on Long-term Survival in Patients After Lung Cancer Surgery: A Randomized Controlled Trial[NCT02801409] | 400 participants (Actual) | Interventional | 2015-05-25 | Completed | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
2 other studies available for 3-methylcholanthrene and Minimal Disease, Residual
| Article | Year |
|---|---|
Adaptive immunity maintains occult cancer in an equilibrium state.
Topics: Animals; Antibodies, Monoclonal; Cell Proliferation; Disease Progression; DNA-Binding Proteins; Fema | 2007 |
Interleukin-2 gene therapy of surgical minimal residual tumour disease.
Topics: Animals; Genetic Therapy; Immunologic Memory; Interleukin-2; Lymphocyte Count; Lymphocyte Subsets; M | 1998 |